Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
Ferric chloride hexahydrate; Zinc chloride; Manganese chloride tetrahydrate; Copper chloride dihydrate; Chromium trichloride hexahydrate; Sodium selenite anhydrous; Sodium molybdate dihydrate; Sodium fluoride; Potassium iodide
Fresenius Kabi Deutschland GmbH
B05XA; B05XA31
Ferric chloride hexahydrate; Zinc chloride; Manganese chloride tetrahydrate; Copper chloride dihydrate; Chromium trichloride hexahydrate; Sodium selenite anhydrous; Sodium molybdate dihydrate; Sodium fluoride; Potassium iodide
10 millilitre(s)
Concentrate for solution for infusion
Electrolyte solutions; electrolytes in combination with other drugs
Not marketed
1988-05-16
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ADDITRACE® CONCENTRATE FOR SOLUTION FOR INFUSION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Additrace is and what it is used for 2. What you need to know before you use Additrace 3. How to use Additrace 4. Possible side effects 5. How to store Additrace 6. Contents of the pack and other information 1. WHAT ADDITRACE IS AND WHAT IT IS USED FOR Additrace provides trace elements into your blood stream when you cannot eat normally. Trace elements are tiny amounts of chemicals that your body needs to work normally. Additrace is usually used as part of a balanced intravenous diet, together with proteins, fat, carbohydrates, salts and vitamins. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE ADDITRACE DO NOT USE ADDITRACE: • if you are allergic to any of the ingredients of Additrace mentioned in section 6. IF YOU DEVELOP A RASH OR OTHER ALLERGIC REACTIONS (LIKE ITCHING, SWOLLEN LIPS OR FACE OR SHORTNESS OF BREATH), PLEASE INFORM YOUR DOCTOR. WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before using Additrace if you suffer from: - impaired liver and/or kidney function Your doctor may want to do regular blood tests to check your condition. Additrace MUST BE DILUTED BEFORE USE. It will be added to another solution before it is given to you. Your doctor, pharmacist or nurse will make sure it is prepared correctly before you receive Additrace. Additrace should not be used if the solution is cloudy or contains particles. The doctor, pharmacist or nurse will check that the solution is particle free before it is administered to you. OTHER MEDICINES AND ADDITRACE Talk to you Lees het volledige document
Health Products Regulatory Authority 26 June 2020 CRN009TTG Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Additrace, concentrate for solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ampoule contains 10ml of concentrate. Each 1 ml of concentrate contains: Ferric chloride, 6H2O Ph. Eur. 540 microgram Zinc chloride Ph. Eur 1.36 mg Manganese chloride 4H 2 O USP 99.0 microgram Copper chloride 2H 2 O USP 340 microgram Chromic chloride 6H 2 O USP 5.33 microgram Sodium Selenite anhydrous 6.9 microgram Sodium molybdate, 2H 2 O Ph. Eur. 4.85 microgram Sodium fluoride BP 210 microgram Potassium iodide Ph. Eur 16.6 microgram One 10ml ampoule of Additrace contains: Fe 3+ 20 micromol Zn 2+ 100 micromol Mn 2+ 5 micromol Cu 2+ 20 micromol Cr 3+ 0.2 micromol Se 4+ 0.4 micromol Mo 6+ 0.2 micromol F - 50 micromol I - 1 micromol Less than 1 mmol of both potassium and sodium. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Concentrate for solution for infusion Sterile, clear, almost colourless solution for addition to amino acid solutions • Osmolality: approx. 3100 mosm/kg water • pH: 2.3 – 2.8 Health Products Regulatory Authority 26 June 2020 CRN009TTG Page 2 of 5 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS A source of electrolytes and trace elements as an integral part of a complete intravenous nutritional regimen, for adults and children over 40 kg. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults_ One 10ml ampoule of Additraceis added to one of the following Vamin solutions: Vamin 9 Glucose, Vamin 14, Vamin 14 Electrolyte-Free, Vamin 18 Electrolyte-Free, Glucose Intravenous Infusion 5-50% The mixture should be infused at an appropriate rate for the amino acid solution. _Paediatric Population_ Additrace is contradindicated in infants and children under 40kg body weight. The electrolyte solution Pedictraceshould be used. Method of administration Intravenous infusion after dilution. Additracemust not be given undiluted. For instruction Lees het volledige document